Pharmaceutical / Drug Definition :
Supplies nicotine during controlled withdrawal from cigarette smoking. Binds selectively to nicotinic-cholinergic receptors in central and peripheral nervous systems, autonomic ganglia, adrenal medulla, and neuromuscular junction. At low doses, has a stimulating effect; at high doses, a reward effect.
In the United States, Nicotine Polacrilex is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Nicotine Polacrilex.
FDA Label Requirements and Exceptions
FDA Import Information
Nicotine Polacrilex (Nicotine Polacrilex Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Nicotine Polacrilex (Nicotine Polacrilex Suppliers)
- Processors Nicotine Polacrilex
- Repackers Nicotine Polacrilex
- Relabelers Nicotine Polacrilex
- Exporters Nicotine Polacrilex
- Importers Nicotine Polacrilex
For more information about Nicotine Polacrilex, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.